Gemcitabine (mg/m²)

DRUG2 trials

Sponsors

H. Lee Moffitt Cancer Center and Research Institute, Medical University of South Carolina

Conditions

Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaPancreatic Cancer

Phase 1

Gem-TABS in Unresectable Pancreatic Carcinoma

CompletedNCT01198821

H. Lee Moffitt Cancer Center and Research InstitutePancreatic Cancer

Start: 2010-08-31End: 2011-06-30Updated: 2017-02-23

Phase 2

Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma

RecruitingNCT07076212

Medical University of South CarolinaLocally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma

Start: 2026-04-02End: 2029-11-01Target: 52Updated: 2026-05-06

Related Papers

Back to basic: Trials and tribulations of alkalizing agents in cancer

Frontiers in Oncology2022-11-1426 citations